Abstract
Objective:
This paper explores the use of pharmacoeconomic methods of valuation to health impacts resulting from exposure to poor air quality. In using such methods, interventions that reduce exposure to poor air quality can be directly compared, in terms of value for money (or cost-effectiveness), with competing demands for finite resources, including other public health interventions.
Design:
Using results estimated as part of a health impact assessment regarding a West Yorkshire Low Emission Zone strategy, this paper quantifies cost-saving and health-improving implications of transport policy through its impact on air quality.
Data source:
Estimates of HRQoL and NHS/PSS costs for identified health events were based on data from Leeds and Bradford using peer-reviewed publications or Office for National Statistics releases.
Population:
Inhabitants of the area within the outer ring roads of Leeds and Bradford.
Main outcomes measures:
NHS and PSS costs and QALYs.
Results:
Averting an all-cause mortality death generates 8.4 QALYs. Each coronary event avoided saves £28,000 in NHS/PSS costs and generates 1.1 QALYs. For every fewer case of childhood asthma there will be NHS/PSS cost saving of £3,000 and a health benefit of 0.9 QALYs. A single term, low birthweight birth avoided saves £2,000 in NHS/PSS costs. Preventing a pre term birth saves £24,000 in NHS/PSS costs and generates 1.3 QALYs. A scenario modelled in the West Yorkshire Low Emission Zone Feasibility Study, where pre EURO 4 buses and HGVs are upgraded to EURO 6 by 2016 generates an annual benefit of £2.08 million and a one-off benefit of £3.3 million compared to a net present value cost of implementation of £6.3 million.
Conclusion:
Interventions to improve air quality and health should be evaluated and where improvement of population health is the primary objective, cost-effectiveness analysis using a NHS/PSS costs and QALYs framework is an appropriate methodology.
This paper explores the use of pharmacoeconomic methods of valuation to health impacts resulting from exposure to poor air quality. In using such methods, interventions that reduce exposure to poor air quality can be directly compared, in terms of value for money (or cost-effectiveness), with competing demands for finite resources, including other public health interventions.
Design:
Using results estimated as part of a health impact assessment regarding a West Yorkshire Low Emission Zone strategy, this paper quantifies cost-saving and health-improving implications of transport policy through its impact on air quality.
Data source:
Estimates of HRQoL and NHS/PSS costs for identified health events were based on data from Leeds and Bradford using peer-reviewed publications or Office for National Statistics releases.
Population:
Inhabitants of the area within the outer ring roads of Leeds and Bradford.
Main outcomes measures:
NHS and PSS costs and QALYs.
Results:
Averting an all-cause mortality death generates 8.4 QALYs. Each coronary event avoided saves £28,000 in NHS/PSS costs and generates 1.1 QALYs. For every fewer case of childhood asthma there will be NHS/PSS cost saving of £3,000 and a health benefit of 0.9 QALYs. A single term, low birthweight birth avoided saves £2,000 in NHS/PSS costs. Preventing a pre term birth saves £24,000 in NHS/PSS costs and generates 1.3 QALYs. A scenario modelled in the West Yorkshire Low Emission Zone Feasibility Study, where pre EURO 4 buses and HGVs are upgraded to EURO 6 by 2016 generates an annual benefit of £2.08 million and a one-off benefit of £3.3 million compared to a net present value cost of implementation of £6.3 million.
Conclusion:
Interventions to improve air quality and health should be evaluated and where improvement of population health is the primary objective, cost-effectiveness analysis using a NHS/PSS costs and QALYs framework is an appropriate methodology.
| Original language | English |
|---|---|
| Article number | e010686 |
| Number of pages | 8 |
| Journal | BMJ Open |
| Volume | 6 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 21 Jun 2016 |
Bibliographical note
This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for detailsKeywords
- Air quality
- Public health
- Health economics
- Quality-Adjusted Life Years
- Economics, Pharmaceutical
- Humans
- England
- Air Pollution/adverse effects
- Public Health/economics
- Cost-Benefit Analysis
- Policy Making
- Quality of Life
- Environmental Monitoring/economics
